19+ Years Horse Chestnut Supplement Manufacturing | OEM, Private Label & Bulk Extract Supply
Popular Horse Chestnut Supplement Concepts
Horse chestnut extract is one of the most established botanical ingredients for vein and circulation health. Over the past two decades, supplement brands have moved beyond single-ingredient products toward synergistic formulations targeting specific consumer groups and health concerns.
As an experienced horse chestnut supplement manufacturer, we help brands develop formulations based on market demand, scientific evidence, and emerging consumer trends. Below are some of the most commercially successful formulation concepts currently available.
Athletes and physically active consumers often experience temporary muscle fatigue, localized swelling, and post-exercise inflammation. Horse chestnut extract can be incorporated into recovery-focused formulations alongside well-established sports nutrition ingredients.
Typical ingredients include:
- Horse Chestnut Extract
- Curcumin Phytosome
- Boswellia Serrata
- Bromelain
- Tart Cherry Extract
Ideal positioning
- Sports recovery
- Active lifestyle
- Exercise recovery
- Muscle wellness
Although marketing claims should remain compliant with local regulations, horse chestnut has long been included in botanical formulations intended to support healthy venous circulation in the anorectal region.
This product concept is commonly found in pharmacy channels throughout Europe.
Typical ingredients include:
- Horse Chestnut Extract
- Butcher’s Broom Extract
- Witch Hazel Extract
- Diosmin
- Hesperidin
Ideal positioning
- Rectal comfort
- Vein wellness
- Pharmacy products
Emerging Horse Chestnut Supplement Trends for 2026
Consumer demand is shifting from single-function supplements toward multifunctional products that combine circulation support with beauty, sports performance, healthy aging, and metabolic wellness. These next-generation concepts provide opportunities for brands to differentiate themselves in increasingly competitive markets.
A growing number of consumers spend extended hours sitting while working remotely or gaming. This has created demand for supplements positioned around healthy circulation and leg comfort for sedentary lifestyles.
Suggested combination
- Horse Chestnut Extract
- Rutin
- Ginkgo Biloba Extract
- Grape Seed Extract
- Vitamin C
Consumer appeal
Office workers, gamers, remote professionals, travel wellness.
The broader vascular health supplements market reached $8.2 billion in 2024 and is forecast to hit $15.6 billion by 2033 at a CAGR of 7.4%.
| Driver | Data Point |
|---|---|
| CVI Prevalence (US) | 10%–35% of adults; 25+ million affected |
| CVI Treatment Market | $2.65 billion (2025) → projected $5.95 billion (2034) at 9.4% CAGR |
| Global Supplement Industry | Surpassed $300 billion in 2025 |
| US Supplement Adoption | 77% of adults consumed a dietary supplement in 2025 |
| Online Channel Growth | 34.6% of distribution; growing at 8.2% CAGR |
- Europe (37.0% market share): Germany leads with Commission E-approved horse chestnut preparations among the top 3 prescribed herbal monopreparations.
- North America (28.5%): US nutraceutical boom fueled by millennial/Gen X demand for evidence-based vein health products.
Asia Pacific (21.5%): Fastest-growing region at 7.8% CAGR, driven by traditional medicine expansion and rising middle-class preventive health spending.
Top Positive Feedback
| Consumer Quotes | Implications for Formulation |
|---|---|
| “Reduced end-of-shift ankle swelling on long-haul routes” | Target occupational health segments (nurses, flight attendants, retail workers) |
| “Less leg heaviness and fatigue during extended standing” | Position for daily wellness and energy support |
| “Noticeable reduction in leg swelling after 2–4 weeks” | Set realistic expectation messaging; emphasize consistency |
| “Improved sense of leg lightness and reduced nighttime cramping” | Market for sleep and recovery positioning |
| “Easy to swallow capsules with no aftertaste” | Prioritize capsule size and coating quality |
| “Ability to wear uniform shoes more comfortably” | Strong visual/functional benefit for marketing |
Top Complaints & Product Gaps
| Consumer Complaint | Manufacturing Solutions |
|---|---|
| “Takes several weeks to notice any difference” | Develop delayed-release capsules for improved absorption and faster onset |
| “GI discomfort, especially on empty stomach” | Enteric-coated or delayed-release formulation; recommend “take with food” labeling |
| “Capsules too large to swallow” | Offer mini-capsules or softgels; consider liquid-filled options |
| “Didn’t work quickly enough” | Combine with Diosmin/Hesperidin for synergistic, faster-acting vein support |
| “Mild nausea or dizziness” | Lower single-dose aescin content; split into twice-daily serving |
| “No noticeable effect after 4 weeks” | Ensure 20% aescin standardization and proper dosing (100–150 mg/day) |
Horse chestnut extract is derived from the seeds of Aesculus hippocastanum L., a deciduous tree native to the Balkan Peninsula. The extract is standardized by its aescin (also known as escin) content—a mixture of triterpene saponins that serve as the primary bioactive compound responsible for its therapeutic effects.
Critical Safety Note for Manufacturers
Raw or unprocessed horse chestnut seeds contain esculin, a toxic coumarin that must be removed during extraction. All commercial horse chestnut seed extract must be properly processed to eliminate esculin and standardized for safe aescin content.
Clinically Validated Benefits
According to the NIH National Center for Complementary and Integrative Health (NCCIH), studies have found that horse chestnut seed extract is beneficial in treating chronic venous insufficiency, with preliminary evidence suggesting it may be as effective as wearing compression stockings.
| Dosage Form | Market Share | Advantages | MOQ | Lead Time |
|---|---|---|---|---|
| Horse Chestnut Capsules | 36.4% | Most popular; easy dosing; delayed-release options available | 100,000 units | 30–45 days |
| Horse Chestnut Tablets | 22.7% | Cost-effective; stable shelf life; film-coated options | 100,000 units | 30–45 days |
| Horse Chestnut Powder | 14.2% | Bulk ingredient supply; flexible for functional foods | 25 kg | 20–30 days |
| Horse Chestnut Gummies | Growing | Consumer preference; pleasant taste; high compliance | 50,000 units | 45–60 days |
| Horse Chestnut Softgels | Niche | Enhanced bioavailability; oil-soluble co-ingredients | 200,000 units | 45–60 days |
| Horse Chestnut Sachets / Stick Packs | Emerging | Convenience; single-serve; travel-friendly | 50,000 units | 35–50 days |
Raw Material Specifications
| Parameter | Standard |
|---|---|
| Botanical Source | Aesculus hippocastanum L. seeds |
| Active Marker | Aescin / Escin (β-escin primary) |
| Standardization | 16–20% aescin (UV); 20% UV; 40% UV; 98% titration available |
| Appearance | Yellowish-brown to off-white powder |
| Esculin Content | <0.1% (toxic constituent removed) |
| Solubility | Water-soluble saponin fraction |
| Test Method | HPLC, UV spectrophotometry |
Quality & Compliance
- Identity Testing: HPLC, UV spectrophotometry
- Heavy Metals: Meets USP <231> / EU standards
- Microbial Limits: USP <61>, <62> compliant
- Pesticide Residues: EU Regulation 396/2005 compliant
- Shelf Life: 24–36 months under proper storage
| Service | Description |
|---|---|
| OEM (Original Equipment Manufacturing) | Your formula, our production. Full compliance with your specifications. |
| ODM (Original Design Manufacturing) | We develop custom formulations based on your target market and positioning. |
| Private Label | Ready-to-market formulations with your branding and packaging. |
| Bulk Supply | Horse chestnut extract powder and raw materials for in-house production. |
OEM Manufacturing Workflow
Raw Material Qualification & Sourcing
↓
Identity Testing & COA Verification
↓
Formula Development & Stability Testing
↓
Pilot Batch Production (Sample Approval)
↓
In-Process Quality Control (IPC)
↓
Full-Scale Production
↓
Finished Product QC (Microbial, Heavy Metals, Potency)
↓
Packaging & Labeling
↓
Final Release & Shipping Documentation- Seed Sourcing & Authentication (European cultivated sources)
- Drying & Milling
- Solvent Extraction & Concentration (food-grade ethanol/water)
- Standardization & Assay (HPLC for aescin quantification)
- Stability Testing & Documentation
| Packaging Type | Best For | Features |
|---|---|---|
| PET/HDPE Bottles | Capsules, Tablets, Softgels | Standard 60–180 count; child-resistant caps; desiccant included |
| Blister Packs | Tablets, Capsules | Tamper-evident; unit-dose; pharmacy-friendly; travel retail |
| Stand-Up Pouches | Powders, Gummies | Resealable; lower shipping weight; Amazon FBA optimized |
| Stick Packs / Sachets | Powder sticks | Single-serve; convenience; sampling programs |
| Glass Jars | Premium powders | Premium positioning; recyclable; health food store appeal |
| Display Boxes | Retail-ready | Shelf-ready packaging; master carton included |
| Retail-Ready Master Cartons | Multi-unit retail | Pre-labeled; barcode included; direct-to-retail distribution |
| Product Type | MOQ | Lead Time | Notes |
|---|---|---|---|
| Horse Chestnut Capsules | 100,000 units | 30–45 days | Delayed-release coating adds 5–7 days |
| Horse Chestnut Tablets | 100,000 units | 30–45 days | Film-coated or enteric-coated available |
| Horse Chestnut Powder | 25 kg | 20–30 days | Bulk; can be packed into jars or pouches |
| Horse Chestnut Gummies | 50,000 units | 45–60 days | Custom flavor development available |
| Horse Chestnut Softgels | 200,000 units | 45–60 days | Liquid-filled; enhanced bioavailability |
| Horse Chestnut Sachets | 50,000 units | 35–50 days | Single-serve powder or granules |
- FDA-Registered Facility — 21 CFR Part 111 compliant
- GMP-Certified — Current Good Manufacturing Practices
- ISO 9001 — Quality management systems
- HACCP — Hazard analysis and critical control points
- EU Export Documentation — COA, MSDS, Stability Data, Written Confirmations
- Third-Party Testing — Independent lab verification for heavy metals, microbes, and potency
- Esculin Removal: All extracts verified to contain negligible esculin levels (<0.1%)
- Delayed-Release Coating: Recommended to reduce GI side effects (nausea, abdominal upset reported in <3% of users)
- Drug Interaction Labeling: Products include appropriate cautions for anticoagulant users (warfarin, heparin, aspirin)
- Pregnancy Warning: High-dose formulations contraindicated in pregnancy and lactation per standard herbal references
- DSHEA Compliance: All US-bound products meet FDA dietary supplement labeling requirements
- EU Traditional Herbal Medicinal Products Directive: Documentation available for European market entry
Why Partner With KS Nutripharma®
Manufacturing Scale & Infrastructure
| Metric | Specifications |
|---|---|
| Years in Operation | 19+ years |
| Total Facility Area | 81,000+ m² (≈872,000 sq ft) GMP-compliant production campus |
| Manufacturing Bases | 5 dedicated production facilities |
| Employees | 260+ |
| Supplement Production Lines | 7 high-speed, automated lines |
| Raw Material Processing Lines | 5 dedicated lines for extract concentration, drying, and milling |
| Cultivation Bases | 4 raw material cultivation bases for traceable botanical sourcing |
Daily Production Capacity
| Dosage Form | Daily Output | Annual Capacity (Est.) |
|---|---|---|
| Softgels | 2+ million / day | 600+ million / year |
| Hard Capsules | 5+ million / day | 1.5+ billion / year |
| Tablets | 12+ million / day | 3.6+ billion / year |
| Gummies | 2+ million / day | 600+ million / year |
| Powder & Granules | – | 5,000+ tons raw material capacity/year |
Research & Development
| R&D Infrastructure | Details |
|---|---|
| R&D Centers | 2 independent research and development centers |
| Formulation Library | 500+ developed and commercialized formulations |
| Services | Custom formula development, stability testing, bioavailability optimization, taste masking, and regulatory documentation |
Quality Assurance & Certifications
- GMP Certified — Current Good Manufacturing Practice for dietary supplements
- FDA Registered — US FDA facility registration; 21 CFR Part 111 compliant
- ISO 9001 — Quality management systems
- HACCP — Hazard Analysis Critical Control Points
- HALAL Certified — Suitable for Muslim markets
- KOSHER Certified — Suitable for Jewish dietary laws
- BRCGS — Global food safety standard
- EU export documentation (COA, MSDS, stability data, written confirmations)
- Health Canada and TGA (Australia) regulatory packages available
- Third-party lab verification for heavy metals, microbes, and potency on request
Global Reach & Brand Partnerships
| Metric | Details |
|---|---|
| Exported Countries | 60+ |
| Global Brands Served | 500+ |
| Supply Chain | Direct sourcing from 4 cultivation bases and 5 raw material processing lines |
Vertical Integration: From Seed to Shelf
4 Cultivation Bases
↓
5 Raw Material Processing Lines (extraction, concentration, drying)
↓
7 Supplement Production Lines (softgels, capsules, tablets, gummies, powders)
↓
QC & Stability Testing
↓
Packaging & Global Logistics- Consistent potency — Direct control over raw material standardization
- Competitive pricing — No middleman markup on key actives like horse chestnut extract
- Full traceability — Lot-to-lot tracking from cultivation to finished product
- Faster lead times — In-house raw material inventory reduces procurement delays
Benefits for Your Horse Chestnut Supplement Line
| Your Requirement | Our Capability |
|---|---|
| High-volume orders | 12+ million tablets/day or 5+ million capsules/day capacity |
| Complex formulations | Multi-ingredient blends, 20% aescin standardization, delayed-release coatings |
| Tight lead times | 5 manufacturing bases allow parallel production scheduling |
| Global compliance | 7 certifications + export documentation for 60+ countries |
| Flexible MOQ | Pilot-friendly for new launches; volume pricing for established brands |
| End-to-end service | Raw material sourcing → R&D → production → QC → packaging → logistics |
Ready to Manufacture at Scale?
- Virtual facility tour of our 81,000+ m² campus
- Custom horse chestnut OEM / ODM proposal
- Bulk horse chestnut extract powder pricing and COA review
- Sample requests and formulation consultation
For OEM and private label projects, we typically provide a comprehensive documentation package to support product development, regulatory review, import clearance, and commercial launch.
Standard Documentation Package
Raw Material Documents
Certificate of Analysis (COA)
Specification Sheet
Ingredient Origin Statement
Allergen Statement
Non-GMO Statement (if applicable)
Halal / Kosher Certificates (if requested)
Quality & Safety Documents
Heavy Metal Test Report
Microbiological Test Report
Residual Solvent Report (if applicable)
Third-Party Laboratory Reports (upon request)
Batch Traceability Records
Finished Product Documents
Finished Product COA
Master Formula Sheet
Nutrition Facts / Supplement Facts Draft
Label Compliance Review
Shelf-Life & Stability Summary
Packaging Specification
Regulatory & Export Documents
FDA Registration Information
cGMP Compliance Statement
ISO 22000 / HACCP Certificates
Free Sale Certificate (if available)
Certificate of Origin
Commercial Invoice & Packing List

- NIH NCCIH. Horse Chestnut. National Center for Complementary and Integrative Health.
- Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2012.
- Siebert U, et al. Horse-Chestnut Seed Extract for Chronic Venous Insufficiency: A Criteria-Based Systematic Review. JAMA Dermatol. 1998.
- Dataintelo. Horse Chestnut Extract Market Research Report 2034. 2025.
- Future Market Insights. Horse Chestnut Seed Extract Market: Global Industry Analysis. 2025.
- Dataintelo. Vascular Health Supplements Market Research Report 2033. 2025.
- NIH StatPearls. Venous Insufficiency. NCBI Bookshelf. 2026.
- DelveInsight. Chronic Venous Insufficiency Market Summary. 2025.
- EBSCO Information Services. Horse chestnut as a dietary supplement. 2023.
- Healthline. 7 Health Benefits of Horse Chestnut Extract. 2019.
- DermNet NZ. Horse chestnut extract. 2024.
- De Gruyter. Phytochemical, ethanomedicinal and pharmacological applications of escin. J Basic Clin Physiol Pharmacol. 2020.



